Stem-cell transplantation in children and adults with sickle cell disease: an update

References

• Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science110, 543–548 (1949).
   PubMed Web of Science ®Google Scholar
• Ingram VM. Gene mutations in human hemoglobin: the chemical difference between normal and sickle cell hemoglobin. Nature180, 326–328 (1957).
   PubMed Web of Science ®Google Scholar
• Ashley-Koch A, Yang Q, Olney R. Sickle hemoglobin (HbS) A allele and sickle cell disease. Am. J. Epidemiol.151, 839–845 (2000).
   PubMed Web of Science ®Google Scholar
• Aliyu ZY, Gordeuk V, Sachdev V et al. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am. J. Hematol.83, 485–490 (2008).
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner S, Sleeper L. Cerebrovascular accidents in sickle cell disease rates and risk factors. Blood91, 288–294 (1998).
   PubMed Web of Science ®Google Scholar
• Scothorn D, Price C, Schwartz D. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J. Pediatr.140, 348–354 (2002).
   PubMed Web of Science ®Google Scholar
• Gladwin M, Sachdev V, Jison M et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med.350, 886–895 (2004).
   PubMed Web of Science ®Google Scholar
• Kato G, McGowan V, Machado R et al. Lactate dehydrogenase as a biomarker for hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood107, 2279–2285 (2006).
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Christoulas D, Bilalis A et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial. Blood115, 2354–2363 (2010).
   PubMed Web of Science ®Google Scholar
• Steinberg MH, McCarthy WF, Castro O et al. The risks and benefits of long term use of hydroxyurea in sickle cell anemia: a 17.5 year follow up. Am. J. Hematol.85, 403–408 (2010).
   PubMed Web of Science ®Google Scholar
• Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT III. Bone marrow transplantation in a patient with sickle cell anemia. N. Engl. J. Med.311, 780–783 (1984).
   PubMed Web of Science ®Google Scholar
• Bhatia M, Walters MC. Hematopoietic stem cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant.41, 109–117 (2008).
   PubMed Web of Science ®Google Scholar
• Aduloju S, Palmer S, Eckman J. Mortality in sickle cell patient transitioning from pediatric to adult program: 10 year Grady Comprehensive Sickle Cell Center experience. Blood112, (2008) (Abstract 1426).
   Google Scholar
• Ballas SK, Dampier D. Outcome of transitioning pediatric patients with sickle cell disease to adult programs. Blood104, (2004) (Abstract 3743).
   Google Scholar
• Bachir D, Parent F, Hajj L et al. Prospective multicentric survey on pulmonary hypertension (PH) in adults with sickle cell disease. Blood114(11), 572 (2009).
   PubMedGoogle Scholar
• De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am. J. Hematol.83, 19–25 (2008).
   PubMed Web of Science ®Google Scholar
• Ataga K, Moore C, Jones S et al. Pulmonary hypertension in patients with SCD: a longitudinal study. Br. J. Hematol.134, 109–115 (2006).
   PubMed Web of Science ®Google Scholar
• Guasch A, Navarrete J, Nass K et al. Glomerular involvement in adults with sickle hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. Am. Soc. Nephrol.17, 2228–2235 (2006).
   PubMed Web of Science ®Google Scholar
• Miller RG, Segal JB, Asharet BH et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am. J. Hematol.81, 236–241 (2006).
   PubMed Web of Science ®Google Scholar
• Powars DR, Chan LS, Hiti A et al. Outcome of sickle cell anemia: a 4 decade observational study of 1056 patients. Medicine (Baltimore)84, 363–376 (2005).
   PubMed Web of Science ®Google Scholar
• Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med.335(6), 369–376 (1996).
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Socie G, Kuentz M et al. Long term results of related myeloablative stem cell transplantation to cure sickle cell disease. Blood110(7), 2749–2756 (2007).
   PubMed Web of Science ®Google Scholar
• Hsieh MM, Kang EM, Fitzhugh CD et al. Allogeneic hematopoietic stem cell transplantation for sickle cell disease. N. Engl. J. Med.361, 2309–2317 (2009).
   PubMed Web of Science ®Google Scholar
• Walters MC, Hardy K, Edwards S et al. Pulmonary, gonadal and central nervous system status after bone marrow transplantation in sickle cell disease. Biol. Blood Marrow Transplant.16(2), 263–272 (2010).
   PubMed Web of Science ®Google Scholar
• Nietert PJ, Abboud MR, Silverstein MD et al. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood95(10), 3057–3064 (2000).
   PubMed Web of Science ®Google Scholar
• Adams RJ, Brambilla D. Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) trial investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N. Engl. J. Med.353(26), 2769–2778 (2005).
   PubMed Web of Science ®Google Scholar
• Bunn HF, Nathan D, Dover GJ et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood116, 687–692 (2010).
   PubMed Web of Science ®Google Scholar
• Dahoui HA, Hayek MN, Nietert PJ et al. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr. Blood Cancer54(3), 398–402 (2010).
   PubMed Web of Science ®Google Scholar
• Minniti CP, Sable C, Campbell A et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica94(3), 340–347 (2009).
   PubMed Web of Science ®Google Scholar
• Colombatti R, Maschietto N, Varotto E et al. Pulmonary hypertension in sickle cell disease children under 10 years of age. Br. J. Haematol.150(5), 601–609 (2010).
   PubMed Web of Science ®Google Scholar
• Hankins J, Hinds P, Day S et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Ped. Blood Cancer48, 705–710 (2007).
   PubMed Web of Science ®Google Scholar
• Watson M, Wheatley K, Harrison GA et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared to consolidation chemotherapy alone: analysis of the MRC AML 10 Trial. Cancer86, 1231–1239 (1999).
   PubMed Web of Science ®Google Scholar
• Lukusa AK, Vermylen C, Vanabelle B et al. Bone marrow transplantation or hydroxyurea for bone marrow transplantation for sickle cell anemia: long-term effects on semen variables and hormone profiles. Pediatr. Hematol. Oncol.26(4), 186–194 (2009).
   PubMed Web of Science ®Google Scholar
• Berthaut I, Guignedoux G, Kirsch-Noir F et al. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica93(7), 988–993 (2008).
   PubMed Web of Science ®Google Scholar
• Kodish E, Lantos J, Stocking C et al. Bone marrow transplantation for sickle cell disease. A study of parents’ decisions. N. Engl. J. Med.325(19), 1349–1353 (1991).
   PubMed Web of Science ®Google Scholar
• van Besien K, Koshy M, Anderson-Shaw L et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients’ decisions. Bone Marrow Transplant.28(6), 545–549 (2001).
   PubMed Web of Science ®Google Scholar
• Panepinto JA, Walters MC, Carreras J et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br. J. Hematol.137, 479–485 (2007).
   PubMed Web of Science ®Google Scholar
• Vermylen C, Cornu G, Ferster A et al. Hematopoietic stem cell transplantation in patients with thalassemia and sickle cell anemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant.22(1), 1–6 (1998).
   PubMed Web of Science ®Google Scholar
• Giardini C, Galimberti M, Lucarelli G et al. Bone marrow transplantation in sickle-cell anemia in Pesaro. Bone Marrow Transplant.12(Suppl. 1), 122–123 (1993).
   PubMed Web of Science ®Google Scholar
• Abboud M, Kletzl M, Miller S et al. Bone marrow transplantation for sickle cell disease. Blood90, 229a (1997).
   Web of Science ®Google Scholar
• Ferster A, Corazza F, Vertongen F et al. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. Br. J. Haematol.90(4), 804–808 (1995).
   PubMed Web of Science ®Google Scholar
• McPherson ME, Hutcherson D, Olson E, Haight AE, Horan J, Chiang K-Y. Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT or sickle cell disease. Bone Marrow Transplant.46, 27–33 (2011).
   PubMed Web of Science ®Google Scholar
• Eggleston B, Patience M, Edwards T et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anemia: results of the multicenter study of hematopoietic transplantation for sickle cell anemia. Br. J. Hematol.136, 673–676 (2007).
   PubMed Web of Science ®Google Scholar
• Brachet C, Heinrichs C, Tenoutasse S et al. Children with sickle cell disease: growth and gonadal function after hematopoetic stem cell transplantation. J. Pediatr. Hematol. Oncol.29, 445–450 (2007).
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Bareford D. A survey on patient perception of reduced intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant.39, 447–451 (2007).
   PubMed Web of Science ®Google Scholar
• Andreani M, Nesci S, Lucarelli G et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant.25, 401–404 (2000).
   PubMed Web of Science ®Google Scholar
• Walters MC, Patience M, Leisenring W et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant.7(12), 665–673 (2001).
   PubMed Web of Science ®Google Scholar
• Wu CJ, Gladwin M, Tisdale J et al. Mixed hematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. Br. J. Haematol.139(3), 504–507 (2007).
   PubMed Web of Science ®Google Scholar
• Krisnamurti L, Kharbanda S, Biernacki M et al. Stable long-term donor engraftment following reduced-intensity hematopoetic stem cell transplantation for sickle cell disease. Biol. Blood Marrow Transplant.14, 1270–1278 (2008).
   PubMed Web of Science ®Google Scholar
• Iannone R, Casella JF, Fuchs EJ et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia. Biol. Blood Marrow Transplant.9(8), 519–528 (2003).
   PubMed Web of Science ®Google Scholar
• Horan JT, Liesveld JL, Fenton P et al. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant.35(2), 171–177 (2005).
   PubMed Web of Science ®Google Scholar
• Patriarca F, Skert C, Bonifazi F et al. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. Haematologica91, 1268–1272 (2006).
   PubMed Web of Science ®Google Scholar
• Kersting S, Hene RJ, Koomans HA, Verdonck LF. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant.13, 1169–1175 (2007).
   PubMed Web of Science ®Google Scholar
• Delgado J, Cooper N, Thomson K et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant.12, 75–83 (2006).
   PubMed Web of Science ®Google Scholar
• Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J. Clin. Oncol.12(5), 998–1004 (1994).
   PubMed Web of Science ®Google Scholar
• Fujimaki K, Maruta A, Yoshida M et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant.27(3), 307–310 (2001).
   PubMed Web of Science ®Google Scholar
• Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997. Bone Marrow Transplant.28(3), 283–287 (2001).
   PubMed Web of Science ®Google Scholar
• Horwitz ME, Spasojevic I, Morris A et al. Fludarabine-based non-myeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biol. Blood Marrow Transplant.13(12), 1422–1426 (2007).
   PubMed Web of Science ®Google Scholar
• Biernacki MA, Okam M, Shenoy S et al. Long-term follow-up of adults with severe sickle cell disease after hematopoietic stem cell transplantation using reduced intensity conditioning. Presented at: ASH Annual Meeting. San Diego, CA, USA, 10–13 December 2010.
   Google Scholar
• Bhatia M, Walters MC. Hematopoietic stem cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant.41, 109–117 (2008).
   PubMed Web of Science ®Google Scholar
• Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an Interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood95, 1918–1924 (2000).
   PubMed Web of Science ®Google Scholar
• Brichard B, Vermylen C, Ninane J et al. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J. Pediatr.128(2), 241–243 (1996).
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood101(6), 2137–2143 (2003).
   PubMed Web of Science ®Google Scholar
• Adamkiewicz TV, Szabolcs P, Haight A et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr. Transplant11, 641–644 (2007).
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zecca M, Piras E et al. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br. J. Hematol.143, 548–551 (2008).
   PubMed Web of Science ®Google Scholar
• Sodani P, Isgrò A, Gaziev J et al. Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood115(6), 1296–1302 (2010).
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Payen E, Negre O et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassemia. Nature 16, 467(7313), 318–322 (2010).
   PubMed Web of Science ®Google Scholar
• Greystoke B, Bonanomi S, Carr TF et al. Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities. Br. J. Hematol.142, 257–262 (2008).
   PubMed Web of Science ®Google Scholar
• Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat. Genet.37(4), 435–440 (2005).
   PubMed Web of Science ®Google Scholar